USPH Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . US Physicalrapy
USPH Stock  USD 98.76  1.68  1.73%   
US Physicalrapy financial statements provide useful quarterly and yearly information to potential US Physicalrapy investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on US Physicalrapy financial statements helps investors assess US Physicalrapy's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting US Physicalrapy's valuation are summarized below:
Gross Profit
112 M
Profit Margin
0.0357
Market Capitalization
1.5 B
Enterprise Value Revenue
2.5216
Revenue
639.1 M
We have found one hundred twenty available fundamental measures for US Physicalrapy, which can be analyzed and compared to other ratios and to its peers in the sector. Traders should compare all of US Physicalrapy latest fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The US Physicalrapy's current Market Cap is estimated to increase to about 165.1 M. The US Physicalrapy's current Enterprise Value is estimated to increase to about 151.5 M

US Physicalrapy Total Revenue

635.04 Million

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Total Revenue of 635 M or Gross Profit of 117.6 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0194 or PTB Ratio of 4.71. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

US Physicalrapy Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1 B997.2 M473.8 M
Slightly volatile
Other Current Liabilities11.7 M18.7 M18.9 M
Pretty Stable
Total Current Liabilities107.3 M102.2 M49.3 M
Slightly volatile
Total Stockholder Equity500 M476.2 M225.1 M
Slightly volatile
Property Plant And Equipment Net136 M129.5 M56.9 M
Slightly volatile
Accounts Payable4.1 M3.9 M2.6 M
Slightly volatile
Cash160.5 M152.8 M37.5 M
Slightly volatile
Non Current Assets Total802.1 M763.9 M384.6 M
Slightly volatile
Cash And Short Term Investments160.5 M152.8 M37.5 M
Slightly volatile
Net Receivables27.3 M51.9 M38.8 M
Slightly volatile
Common Stock Shares Outstanding12.9 M14.2 M12.3 M
Slightly volatile
Liabilities And Stockholders Equity1 B997.2 M473.8 M
Slightly volatile
Other Current Assets30.1 M28.7 M11.1 M
Slightly volatile
Other Stockholder Equity261.9 M249.5 M88.4 M
Slightly volatile
Total Liabilities362.2 M345 M155.7 M
Slightly volatile
Property Plant And Equipment Gross225.1 M214.4 M72.4 M
Slightly volatile
Total Current Assets245 M233.4 M89.2 M
Slightly volatile
Short and Long Term Debt Total271.5 M258.6 M107.9 M
Slightly volatile
Non Current Liabilities Total255 M242.8 M106.4 M
Slightly volatile
Short Term Debt82.1 M78.2 M26.3 M
Slightly volatile
Intangible Assets115.2 M109.7 M50.4 M
Slightly volatile
Good Will484.1 M509.6 M922.3 T
Slightly volatile
Common Stock Total Equity144.3 K173.7 K141 K
Slightly volatile
Common Stock147 K172 K141.1 K
Slightly volatile
Other Assets2.1 M1.9 M2.3 M
Pretty Stable
Long Term Debt145.9 M139 M64.2 M
Slightly volatile
Property Plant Equipment154.3 M146.9 M48.8 M
Slightly volatile
Current Deferred Revenue1.9 M3.3 M2.7 M
Very volatile
Other Liabilities41.5 M39.5 M14.2 M
Slightly volatile
Long Term Debt Total142 M135.2 M61.8 M
Slightly volatile
Capital Surpluse73.5 M118.1 M69.6 M
Slightly volatile
Non Current Liabilities Other4.2 M2.4 M4 M
Pretty Stable
Warrants106 M178.6 M82.6 M
Slightly volatile
Short and Long Term Debt8.1 M7.7 M2.8 M
Slightly volatile
Net Invested Capital415.9 M622.9 M328.1 M
Slightly volatile
Capital Stock169.6 K172 K152.4 K
Slightly volatile
Capital Lease Obligations111 M111.9 M93.1 M
Slightly volatile

US Physicalrapy Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue635 M604.8 M387.2 M
Slightly volatile
Gross Profit117.6 M112 M85.8 M
Slightly volatile
Other Operating Expenses562 M535.2 M334.7 M
Slightly volatile
Cost Of Revenue517.5 M492.8 M301.4 M
Slightly volatile
Total Operating Expenses23.1 M42.4 M31.9 M
Slightly volatile
Income Tax Expense7.7 M12.2 M11.1 M
Slightly volatile
Depreciation And Amortization16.5 M15.7 M9.6 M
Slightly volatile
Income Before Tax31.9 M49.4 M45.9 M
Slightly volatile
Selling General Administrative26.7 M52 M34 M
Slightly volatile
Net Income Applicable To Common Shares19.8 M33.7 M25 M
Slightly volatile
Net Income From Continuing Ops42.3 M41.9 M38.1 M
Slightly volatile
Non Recurring4.7 M4.9 M4.3 M
Slightly volatile
Non Operating Income Net Other2.3 M2.9 M2.4 M
Pretty Stable
Tax Provision13.3 M12 M12.7 M
Pretty Stable
Interest Income3.2 M3 M3.4 M
Slightly volatile
Reconciled Depreciation12.9 M15.4 M10.8 M
Slightly volatile
Extraordinary Items3.4 M3.9 M4.2 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.6 M9.3 M
Slightly volatile

US Physicalrapy Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures5.3 M9.3 M6.3 M
Slightly volatile
End Period Cash Flow160.5 M152.8 M37.4 M
Slightly volatile
Begin Period Cash Flow33.2 M31.6 M19.4 M
Slightly volatile
Depreciation16.5 M15.7 M9.2 M
Slightly volatile
Stock Based Compensation4.5 M7.2 M5 M
Slightly volatile
Dividends Paid25.3 M24.1 M11.9 M
Slightly volatile
Change To Netincome39.9 M38 M18.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.992.1853.8326
Slightly volatile
Dividend Yield0.01940.01830.0161
Slightly volatile
PTB Ratio4.712.77514.3389
Very volatile
Days Sales Outstanding62.3631.301341.4968
Slightly volatile
Book Value Per Share48.2745.971124.4432
Slightly volatile
Stock Based Compensation To Revenue0.0090.0120.0121
Slightly volatile
Capex To Depreciation1.080.59220.783
Very volatile
PB Ratio4.712.77514.3389
Very volatile
EV To Sales2.892.35983.7515
Slightly volatile
ROIC0.07570.07970.1366
Slightly volatile
Payables Turnover89.28126127
Very volatile
Sales General And Administrative To Revenue0.120.08590.0992
Slightly volatile
Capex To Revenue0.01460.01540.0383
Slightly volatile
Cash Per Share11.5110.95912.8345
Slightly volatile
Payout Ratio1.731.64430.6027
Slightly volatile
Days Payables Outstanding5.292.8874.4969
Slightly volatile
Income Quality2.22.20251.6316
Slightly volatile
Intangibles To Total Assets0.310.6210.6263
Pretty Stable
Net Debt To EBITDA1.491.4221.3894
Very volatile
Current Ratio2.172.28382.6198
Slightly volatile
Receivables Turnover5.8411.66098.9562
Slightly volatile
Graham Number29.3427.947126.6981
Slightly volatile
Shareholders Equity Per Share35.2433.563217.3164
Slightly volatile
Debt To Equity0.470.38210.3559
Slightly volatile
Capex Per Share0.330.65510.4941
Slightly volatile
Revenue Per Share44.7642.627730.0995
Slightly volatile
Interest Debt Per Share14.1513.47887.4039
Slightly volatile
Debt To Assets0.210.18240.1716
Slightly volatile
Short Term Coverage Ratios1.811.90937.9033
Slightly volatile
Operating Cycle62.2731.301341.3332
Slightly volatile
Price Book Value Ratio4.712.77514.3389
Very volatile
Days Of Payables Outstanding5.292.8874.4969
Slightly volatile
Dividend Payout Ratio1.731.64430.6027
Slightly volatile
Pretax Profit Margin0.0880.08160.1246
Slightly volatile
Ebt Per Ebit0.660.70990.9495
Slightly volatile
Effective Tax Rate0.330.24620.2714
Slightly volatile
Company Equity Multiplier1.472.09421.9029
Slightly volatile
Long Term Debt To Capitalization0.260.22590.225
Slightly volatile
Total Debt To Capitalization0.280.27640.2463
Slightly volatile
Debt Equity Ratio0.470.38210.3559
Slightly volatile
Quick Ratio2.172.28382.622
Slightly volatile
Net Income Per E B T0.280.29720.5162
Pretty Stable
Cash Ratio1.731.49561.2919
Slightly volatile
Days Of Sales Outstanding62.3631.301341.4968
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.88660.9402
Slightly volatile
Price To Book Ratio4.712.77514.3389
Very volatile
Fixed Asset Turnover8.284.669112.5021
Slightly volatile
Debt Ratio0.210.18240.1716
Slightly volatile
Price Sales Ratio2.992.1853.8326
Slightly volatile
Asset Turnover0.580.60650.9246
Slightly volatile
Gross Profit Margin0.290.18520.2308
Very volatile
Price Fair Value4.712.77514.3389
Very volatile

US Physicalrapy Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap165.1 M157.2 M162.3 M
Slightly volatile
Enterprise Value151.5 M144.3 M148.9 M
Slightly volatile

USPH Fundamental Market Drivers

Forward Price Earnings39.2157
Cash And Short Term Investments152.8 M

USPH Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's revenue or net income, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M1.9 M
Total Revenue604.8 M635 M
Cost Of Revenue492.8 M517.5 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.09  0.12 
Capex To Revenue 0.02  0.01 
Revenue Per Share 42.63  44.76 
Ebit Per Revenue 0.12  0.07 

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
How To Invest In USPH
Details
Is USPH Stock a good investment?
Details
What is US Physicalrapy's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.75
Earnings Share
0.88
Revenue Per Share
42.489
Quarterly Revenue Growth
0.12
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY